{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-009320","form_type":"8-K","ticker":"GLUE","cik":"0001826457","company_name":"Monte Rosa Therapeutics, Inc.","filed_at":"2023-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.850388+00:00","generated_at":"2026-06-17T19:10:07.800834+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Monte Rosa Therapeutics appoints Jan Skvarka to Board of Directors","bullets":["Appointed Jan Skvarka, Ph.D., MBA to the Board, effective March 23, 2023.","Skvarka will serve as a Class I director until the 2025 annual meeting.","Board determined Skvarka is independent under Nasdaq listing standards.","Compensation follows Non-Employee Director Compensation Policy; entered indemnification agreement.","No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-009320","json":"https://secwatch.observer/filing/0000950170-23-009320.json","markdown":"https://secwatch.observer/filing/0000950170-23-009320.md","text":"https://secwatch.observer/filing/0000950170-23-009320.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826457/000095017023009320/0000950170-23-009320-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826457/000095017023009320/glue-20230323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T19:10:07.800834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"77b9f9ae07","claim":"Jan Skvarka was appointed as Director at Monte Rosa Therapeutics, Inc..","evidence_excerpt":"the Board appointed Jan Skvarka, Ph.D., MBA to join the Board, effective as of March 23, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826457/000095017023009320/0000950170-23-009320-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}